Literature DB >> 11438460

High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

A Maitra1, I I Wistuba, C Washington, A K Virmani, R Ashfaq, S Milchgrub, A F Gazdar, J D Minna.   

Abstract

We performed high-resolution allelotyping for loss of heterozygosity (LOH) analysis on microdissected samples from 45 primary breast cancers, 47 mammary preneoplastic epithelial foci, and 18 breast cancer cell lines, using a panel of 27 polymorphic chromosome 3p markers. Allele loss in some regions of chromosome 3p was detected in 39 of 45 (87%) primary breast tumors. The 3p21.3 region had the highest frequency of LOH (69%), followed by 3p22-24 (61%), 3p21.2-21.3 (58%), 3p25 (48%), 3p14.2 (45%), 3p14.3 (41%), and 3p12 (35%). Analysis of all of the data revealed at least nine discrete intervals showing frequent allele loss: D3S1511-D3S1284 (U2020/DUTT1 region centered on D3S1274 with a homozygous deletion), D3S1300-D3S1234 [fragile histidine triad (FHIT)/FRA3B region centered on D3S1300 with a homozygous deletion], D3S1076-D3S1573, D3S4624/Luca2.1-D3S4597/P1.5, D3S1478-D3S1029, D3S1029 (with a homozygous deletion), D3S1612-D3S1537, D3S1293-D3S1597, and D3S1597-telomere; it is more than likely that additional localized regions of LOH not examined in this study also exist on chromosome 3p. In multiple cases, there was discontinuous allele loss at several 3p sites in the same tumor. Twenty-one of 47 (45%) preneoplastic lesions demonstrated 3p LOH, including 12 of 13 (92%) ductal carcinoma in situ, 2 of 7 (29%) apocrine metaplasia, and 7 of 25 (28%) usual epithelial hyperplasia. The 3p21.3 region had the highest frequency of LOH in preneoplastic breast epithelium (36%), followed by 3p21.2-21.3 (20%), 3p14.2/FHIT region (11%), 3p25 (10%), and 3p22-24 (5%). In 39 3p loci showing LOH in both the tumor and accompanying preneoplasia, 34 (87%) showed loss of the same parental allele (P = 1.2 x 10(-6), cumulative binomial test). In addition, when 21 preneoplastic samples showing LOH were compared to their accompanying cancers, 67% were clonally related, 20% were potentially clonally related but were divergent, and 13% were clonally unrelated. Overall this demonstrated the high likelihood of clonal relatedness of the preneoplastic foci to the tumors. We conclude that: chromosome 3p allele loss is a common event in breast carcinoma pathogenesis; involves multiple, localized sites that often show discontinuous LOH with intervening markers retaining heterozygosity; and is seen in early preneoplastic stages, which demonstrate clonal relatedness to the invasive cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11438460      PMCID: PMC1850416          DOI: 10.1016/S0002-9440(10)61679-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  68 in total

1.  A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.

Authors:  R J Osborne; M G Hamshere
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

2.  Loss of heterozygosity induced by a chromosomal double-strand break.

Authors:  M E Moynahan; M Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

Authors:  M Widschwendter; J Berger; M Hermann; H M Müller; A Amberger; M Zeschnigk; A Widschwendter; B Abendstein; A G Zeimet; G Daxenbichler; C Marth
Journal:  J Natl Cancer Inst       Date:  2000-05-17       Impact factor: 13.506

4.  Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.

Authors:  C Y Shen; J C Yu; Y L Lo; C H Kuo; C T Yue; Y S Jou; C S Huang; J C Lung; C W Wu
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

5.  Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.

Authors:  C Washington; F Dalbègue; F Abreo; J K Taubenberger; J H Lichy
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Authors:  R Dammann; C Li; J H Yoon; P L Chin; S Bates; G P Pfeifer
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.

Authors:  I I Wistuba; F D Montellano; S Milchgrub; A K Virmani; C Behrens; H Chen; M Ahmadian; J A Nowak; C Muller; J D Minna; A F Gazdar
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

8.  FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.

Authors:  M Campiglio; Y Pekarsky; S Menard; E Tagliabue; S Pilotti; C M Croce
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

9.  Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.

Authors:  I I Wistuba; G E Tomlinson; C Behrens; A Virmani; J Geradts; J L Blum; J D Minna; A F Gazdar
Journal:  Genes Chromosomes Cancer       Date:  2000-08       Impact factor: 5.006

10.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

Authors:  C S Huang; H D Chern; K J Chang; C W Cheng; S M Hsu; C Y Shen
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  41 in total

1.  Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil.

Authors:  S C L Santos; L R Cavalli; I J Cavalli; R S Lima; B R Haddad; E M S F Ribeiro
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.

Authors:  Erika da Costa Prando; Luciane Regina Cavalli; Cláudia Aparecida Rainho
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

Review 3.  The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.

Authors:  Anne W Hamburger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-19       Impact factor: 2.673

Review 4.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

5.  Identification of 5 novel genes methylated in breast and other epithelial cancers.

Authors:  Victoria K Hill; Luke B Hesson; Temuujin Dansranjavin; Ashraf Dallol; Ivan Bieche; Sophie Vacher; Stella Tommasi; Timothy Dobbins; Dean Gentle; David Euhus; Cheryl Lewis; Reinhard Dammann; Robyn L Ward; John Minna; Eammon R Maher; Gerd P Pfeifer; Farida Latif
Journal:  Mol Cancer       Date:  2010-03-05       Impact factor: 27.401

6.  Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.

Authors:  Tapasya Srivastava; Kunzang Chosdol; Parthaprasad Chattopadhayay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  J Neurooncol       Date:  2006-10-04       Impact factor: 4.130

7.  Transposable elements and miRNA: Regulation of genomic stability and plasticity.

Authors:  Irene Munk Pedersen; Dimitrios G Zisoulis
Journal:  Mob Genet Elements       Date:  2016-04-08

8.  Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.

Authors:  Maria Kost-Alimova; Hajnalka Kiss; Ludmila Fedorova; Ying Yang; Jan P Dumanski; George Klein; Stefan Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

9.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

10.  Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.

Authors:  H Iijima; Y Tomizawa; K Dobashi; R Saito; T Nakajima; M Mori
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.